Moxyplit 150 Injection

Composition : Amoxycillin (125mg) + Clavulanic Acid (25mg)

Dosage Form : Injection

Packaging Type :

Packaging : vial

Price : ₹79/-

Please Contact For Best Price

Moxyplit 150 Injection is a potent combination of amoxicillin and clavulanic acid, specifically formulated to combat various bacterial infections. Amoxicillin, a broad-spectrum penicillin antibiotic, works by inhibiting the growth of bacteria, while clavulanic acid serves as a beta-lactamase inhibitor, enhancing the effectiveness of amoxicillin against resistant strains. This synergistic formulation is designed for parenteral administration, ensuring rapid absorption and efficacy in treating a range of infections, including those affecting the respiratory tract, urinary system, skin, and soft tissues.

Moxyplit 150 is especially useful in cases where infections are caused by beta-lactamase producing bacteria that may otherwise resist treatment with amoxicillin alone. This makes it a vital option in clinical settings, particularly for patients who may be unable to tolerate oral medications due to severe illness or gastrointestinal complications.

The injection is typically administered under the supervision of a healthcare professional, ensuring proper dosing and monitoring for any potential reactions. Its formulation allows for precise dosage adjustments based on the severity of the infection and the patient’s overall health condition.

Read More

About the Product

Moxyplit 150 Injection is a potent combination of amoxicillin and clavulanic acid, specifically formulated to combat various bacterial infections. Amoxicillin, a broad-spectrum penicillin antibiotic, works by inhibiting the growth of bacteria, while clavulanic acid serves as a beta-lactamase inhibitor, enhancing the effectiveness of amoxicillin against resistant strains. This synergistic formulation is designed for parenteral administration, ensuring rapid absorption and efficacy in treating a range of infections, including those affecting the respiratory tract, urinary system, skin, and soft tissues.

Moxyplit 150 is especially useful in cases where infections are caused by beta-lactamase producing bacteria that may otherwise resist treatment with amoxicillin alone. This makes it a vital option in clinical settings, particularly for patients who may be unable to tolerate oral medications due to severe illness or gastrointestinal complications.

The injection is typically administered under the supervision of a healthcare professional, ensuring proper dosing and monitoring for any potential reactions. Its formulation allows for precise dosage adjustments based on the severity of the infection and the patient’s overall health condition.

Common side effects may include gastrointestinal disturbances, allergic reactions, and local injection site reactions. Monitoring for serious side effects is essential.

Moxyplit 125 Injection is indicated for the treatment of moderate to severe infections caused by susceptible bacteria, particularly those resistant to other antibiotics.

This medication should be used under medical supervision, and patients should inform their healthcare provider of any known allergies or existing medical conditions before administration.

Get in Touch